子宫非典型息肉样腺肌瘤研究进展

doi:10.12280/gjszjk.20230276

摘要/Abstract

摘要：

非典型息肉样腺肌瘤（atypical polypoid adenomyoma，APA）是一种罕见的子宫上皮和间质混合肿瘤。其发病机制尚不明确，可能与雌激素水平升高有关。主要临床表现为不规则阴道出血及不孕等。APA的影像学检查缺乏特征性，确诊需依据组织病理学，镜下组织结构常复杂多样，免疫组织化学是辅助诊断的重要方法。APA是良性肿瘤，但具有恶性潜能，有进展成子宫内膜癌的风险，临床上容易漏诊、误诊。目前，结合患者的生育要求、年龄及术后病理诊断选择个体化的治疗方案。综述APA的发病机制、临床表现、诊断和治疗及其预后的最新进展。

关键词: 非典型息肉样腺肌瘤, 临床病理, 免疫组织化学, 治疗, 随访

Abstract:

Atypical polypoid adenomyoma (APA) is a rare uterine epithelial and stromal tumor. The pathogenesis of APA is not clear, and it may be related to the increased level of estrogen. The main clinical manifestations were irregular vaginal bleeding and infertility. The characteristics of imaging examination of APA are atypical, the diagnosis depends on histopathology. The tissue structure under the microscopy is often complex and diverse. Immunohistochemistry is an important method to assist the diagnosis. APA is a benign tumor, but with malignant potential, there is a risk of progression into endometrial cancer. It is easy to miss diagnosis or misdiagnosis clinically. At present, the clinical treatment strategy of APA is to select the individualized treatment according to the fertility requirements, age and postoperative pathological diagnosis. The pathogenesis, clinical manifestations, diagnosis, treatment and prognosis of APA were reviewed.

Key words: Atypical polypoid adenomyoma, Clinicopathology, Immunohistochemistry, Therapy, Follow-up

肖婉婷, 邹倩. 子宫非典型息肉样腺肌瘤研究进展[J]. 国际生殖健康/计划生育杂志, 2023, 42(6): 524-528.

XIAO Wan-ting, ZOU Qian. Research Progress of Atypical Polypoid Adenomyoma of the Uterus[J]. Journal of International Reproductive Health/Family Planning, 2023, 42(6): 524-528.

参考文献 29

[1]	中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6):376-383. doi: 10.3760/cma.j.cn112141-20200228-00150.
[2]	Thanasa EI, Thanasa AI, Paraoulakis IE, et al. Surgical treatment of a rare case of atypical polypoid adenomyoma of the uterus in a menopausal patient: a case report[J]. Pan Afr Med J, 2023, 44:118. doi: 10.11604/pamj.2023.44.118.39256. pmid: 37275297
[3]	Sun Y, Tian L, Liu G. A Clinicopathological Review of 203 Cases of Atypical Polypoid Adenomyoma of the Uterus[J]. J Clin Med, 2023, 12(4):1511. doi: 10.3390/jcm12041511.
[4]	McCluggage WG, Singh N, Gilks CB. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition(2020)[J]. Histopathology, 2022, 80(5):762-778. doi: 10.1111/his.14609. pmid: 34996131
[5]	Travaglino A, Raffone A, Saccone G, et al. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis[J]. Appl Immunohistochem Mol Morphol, 2020, 28(8):646-653. doi: 10.1097/PAI.0000000000000780. pmid: 31855579
[6]	Biasioli A, Londero AP, Orsaria M, et al. Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis[J]. Medicine (Baltimore), 2020, 99(26):e20491. doi: 10.1097/MD.0000000000020491.
[7]	Takahashi H, Yoshida T, Matsumoto T, et al. Frequent β-catenin gene mutations in atypical polypoid adenomyoma of the uterus[J]. Hum Pathol, 2014, 45(1):33-40. doi: 10.1016/j.humpath.2013.06.020. pmid: 24182564
[8]	Lu B, Yu M, Shi H, et al. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features[J]. Pathol Res Pract, 2019, 215(4):766-771. doi: 10.1016/j.prp.2019.01.016. pmid: 30661903
[9]	Horita A, Kurata A, Maeda D, et al. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon[J]. Int J Gynecol Pathol, 2011, 30(1):64-70. doi: 10.1097/PGP.0b013e3181efbe29. pmid: 21131830
[10]	Longacre TA, Chung MH, Rouse RV, et al. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases[J]. Am J Surg Pathol, 1996, 20(1):1-20. doi: 10.1097/00000478-199601000-00001. pmid: 8540600
[11]	Wang X, Guo Y. Clinical analysis of 44 cases of atypical polypoid adenomyoma of the uterus[J]. BMC Womens Health, 2022, 22(1):60. doi: 10.1186/s12905-022-01643-y. pmid: 35246106
[12]	乌兰, 李兵, 袁冬存, 等. 子宫内膜非典型性息肉样腺肌瘤介入术后嵌顿1例[J]. 介入放射学杂志, 2022, 31(7):741-742. doi: 10.3969/j.issn.1008-794X.2022.07.023.
[13]	Javed L, Ashraf N, Sabqat M, et al. Atypical Polypoid Adenomyoma (APAM)[J]. J Coll Physicians Surg Pak, 2021, 30(6):719-721. doi: 10.29271/jcpsp.2021.06.719. pmid: 34102788
[14]	Kalmantis K, Daskalakis G, Semertzidou A, et al. The role of three-dimensional power Doppler hysterosonography(3-DPDS) in distinguishing atypical polypoid adenomyomas (APAs) from other intrauterine tumors: correlation with pathologic findings[J]. Arch Gynecol Obstet, 2017, 296(2):391-396. doi: 10.1007/s00404-017-4436-3.
[15]	Tan Y, Hu X, Song X, et al. MRI and Transvaginal Ultrasound Findings of Atypical Polypoid Adenomyoma: A Case Report[J]. Chin Med Sci J, 2022, 37(1):82-86. doi: 10.24920/003911. pmid: 35256047
[16]	Mitranovici MI, Oală IE, Petre I, et al. Atypical Polypoid Adenomyoma of the Vagina: Follow Up and Subsequent Evolution: A Case Report and Update[J]. Diagnostics (Basel), 2022, 12(2):368. doi: 10.3390/diagnostics12020368.
[17]	王静, 刘艳君, 李平, 等. 子宫颈非典型息肉样腺肌瘤1例[J]. 中国医学影像技术, 2022, 38(11):1760. doi: 10.13929/j.issn.1003-3289.2022.11.045.
[18]	Omori M, Kawai M, Ogawa T, et al. Lesion-targeted cytology to improve cytological sampling for atypical polypoid adenomyomas of the uterus: A case series and review of the literature[J]. Cytopathology, 2020, 31(6):579-585. doi: 10.1111/cyt.12899.
[19]	Zhu H, Bai T, Tian Z, et al. A clinicopathological study of 39 cases of atypical polypoid adenomyoma of the uterus[J]. Gynecol Obstet Clin Med, 2021, 1(3):138-143. doi:10.1016/j.gocm.2021.07.003.
[20]	Worrell HI, Sciallis AP, Skala SL. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling[J]. Histopathology, 2021, 79(1):96-105. doi: 10.1111/his.14338.
[21]	Kihara A, Amano Y, Yoshimoto T, et al. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus[J]. Am J Surg Pathol, 2019, 43(11):1526-1535. doi: 10.1097/PAS.0000000000001320. pmid: 31600177
[22]	Travaglino A, Raffone A, Gencarelli A, et al. Significance of stromal markers in atypical polypoid adenomyoma[J]. Pathol Res Pract, 2020, 216(11):153133. doi: 10.1016/j.prp.2020.153133.
[23]	Ma B, Zhu Y, Liu Y. Management of atypical polypoid adenomyoma of the uterus: A single center′s experience[J]. Medicine (Baltimore), 2018, 97(12):e0135. doi: 10.1097/MD.0000000000010135.
[24]	Nomura H, Sugiyama Y, Tanigawa T, et al. Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate[J]. Arch Gynecol Obstet, 2016, 293(1):177-181. doi: 10.1007/s00404-015-3824-9. pmid: 26209972
[25]	梁杰. 宫腔镜联合孕激素治疗子宫非典型息肉样腺肌瘤的中远期疗效[J]. 实用妇科内分泌电子杂志, 2020, 7(1):12,21. doi:10.16484/j.cnki.issn2095-8803.2020.01.009.
[26]	Solima E, Liprandi V, Belloni GM, et al. Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system[J]. Gynecol Oncol Rep, 2017, 21:84-85. doi: 10.1016/j.gore.2017.07.002.
[27]	Narumi R, Takei Y, Morisawa H, et al. Successful laparotomy tumor resection and levonorgestrel-releasing intrauterine system for atypical polypoid adenomyoma[J]. J Obstet Gynaecol Res, 2019, 45(1):230-234. doi: 10.1111/jog.13783.
[28]	Wong C, So PL. Prevalence and risk factors for malignancy in hysteroscopy-resected endometrial polyps[J]. Int J Gynaecol Obstet, 2021, 155(3):433-441. doi: 10.1002/ijgo.13656. pmid: 33621356
[29]	Weisman P, Park KJ, Xu J. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas[J]. Int J Gynecol Pathol, 2022, 41(2):126-131. doi: 10.1097/PGP.0000000000000775.